Conclusion: The PSA continues to be the most sensitive method for prostate cancer diagnosis. DRE tends to be more negative at early stages of cancer detection. Comparing the conventional TRUS echography with the CDUS, the latter is a better detector in the diagnosis of cancer....
Semi-quantitative analysis of [18F]DCFPyL PET/CT for prostate cancer In semi-quantitative analysis, the SUVmax value for the prostate cancer group was 13.1 ± 8.6, significantly higher than the 3.4 ± 1.4 in the benign lesion group (P < 0.05). The optimal diagnostic threshold...
1. A method to aid in detecting or determining the presence of prostate cancer in a patient, comprising the steps of: a) determining the amount of total PSA contained in a biological sample from the patient; b) determining the amount of free PSA in the sample; and calculating the ratio ...
Prognostic and diagnostic method for cancer therapy The present invention provides novel methods and kits for diagnosing the presence of cancer within a patient, and for determining whether a subject who has cancer is susceptible to different types of treatment regimens. The cancers to be... GV Gl...
Prostate cancer (PC) is an epithelial malignancy occurring in the prostate. PC ranks second in incidence among all male malignancies globally by the latest statistics from the World Health Organization. Notably, China has seen a more rapid increase in PC incidence compared to developed European and...
Methods for discriminating between prostate cancer and a benign prostate-diseaseA method of analyzing diagnostic information, the method including: measuring the concentration of all mucin-1s (total MUC1) in a blood sample originated from a subject to be diagnosed; comparing the measured value with ...
new method for enhancement of histo-pathological diagnosis of prostate cancer Purpose: This study aimed to compare the diagnostic performances of 8 different imaging modalities for preoperative detection of bone metastases in prostat... C Kochiashvili,A Khuskivadze,B Partsvania,... 被引量: 0发表:...
The present invention relates to prostate cancer. More specifically, the present invention relates to a method to detect prostate cancer in a patient sample by detecting the RNA encoded by the gene PCA3. More particularly the present invention relates to a method for determining a predisposition, ...
Prostate-Specific Antigen–Based Screening for Prostate Cancer: A Systematic Evidence Review for the US Preventive Services Task Force: Evidence Synthesis No. 154. Rockville, MD: Agency for Healthcare Research and Quality; 2018. AHRQ publication 17-05229-EF-1. 4. Fenton JJ, Weyrich MS, Durbin ...
A method and assay are described for determining prostate cancer and the general stage of progression of such cancer by quantifying levels of expression of different galectin isofor